Concorde Asset Management, LLC

Position in AMGN — Amgen Inc

CIK 1631773 ANN ARBOR, MI

Position in AMGN

as of Jun 30, 2026 · filed Aug 18, 2026 Compact

Position Value

$309,974

+$15,476 QoQ

Shares Held

856

+2.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.39%

of 13F equity value

Holder Rank

#2,531

of 3,140 holders

Holding Since

Jun 2020

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Concorde Asset Management, LLC holds $2,975,283 across 6 Drug Manufacturers - General names. AMGN ranks #4 (10.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	652	$782,028
2	JNJ	Johnson & Johnson	2,819	$715,941
3	ABBV	AbbVie Inc.	2,581	$649,482
4	AMGN	Amgen Inc This page	856	$309,974
5	PFE	Pfizer Inc	12,833	$309,018
6	GILD	Gilead Sciences, Inc.	1,653	$208,840

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$309,974	856	+2.3%	Shares	Sole	2026-08-18
2026-03-31	$294,498	837	-9.7%	Shares	Sole	2026-06-01
2025-12-31	$303,416	927	-4.9%	Shares	Sole	2026-02-13
2025-09-30	$275,145	975	+10.5%	Shares	Sole	2025-11-14
2025-03-31	$274,787	882	-1.0%	Shares	Sole	2025-05-15
2024-12-31	$232,230	891	-0.6%	Shares	Sole	2025-02-13
2024-09-30	$288,700	896	+0.9%	Shares	Sole	2024-11-12
2024-06-30	$277,455	888	+4.8%	Shares	Sole	2024-08-12
2024-03-31	$240,819	847	-21.9%	Shares	Sole	2024-05-15
2023-12-31	$312,501	1,085	+43.5%	Shares	Sole	2024-02-15
2023-09-30	$203,181	756	-11.8%	Shares	Sole	2023-11-13
2021-06-30	$208,892	857	+0.2%	Shares	Sole	2021-07-20
2021-03-31	$212,731	855	-11.9%	Shares	Sole	2021-04-27
2020-12-31	$223,021	970	+4.1%	Shares	Sole	2021-01-29
2020-09-30	$236,875	932	+4.1%	Shares	Sole	2020-10-23
2020-06-30	$211,093	895	—	Shares	Sole	2020-07-20
No filing history on record for this holder in this stock.